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Regulation and Function of Tenascin-C in Heart Valve Homeostasis
Abstract
Tenascin-C (TN-C) interacts with extracellular molecules and plays a role in cell adhesion, signaling, and
differentiation. There is evidence that TN-C is regulated by mechanical forces and since the heart valve is a
highly dynamic structure, it is possible that TN-C is expressed within specific sites within the aortic valve, as
these sites are subject to unique mechanical forces. It is also reasonable to expect differences in TN-C
expression between the pulmonary and the aortic valve because these two locations experience different levels
of mechanical force. Here we compare TN-C expression levels in adult pulmonary versus aortic valves and
determine if different cell types within aortic valves express different amounts of TNC. Our results indicate
that TN-C is expressed in normal post-natal heart valves and expression is higher on the aortic versus
ventricular side of the aortic valve. TN-C expression may be higher in aortic versus pulmonary valve. SMC,
fibroblasts or myofibroblasts may produce TN-C, but endothelial cells appear not to produce TN-C. These
studies will help us in determining the role TN-C plays in normal heart valve tissue homeostasis and how
different cell types react to different mechanical forces.
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IntroductIon
Heart valves help control the flow of blood through the 
heart’s four chambers.  The upper two are the small, round 
atria, and the lower two are large, cone-shaped ventricles. 
Each ventricle has an inlet valve and an outlet valve to ensure 
that blood flow is unidirectional. In the left ventricle, the inlet 
valve is the mitral valve, and the outlet valve is the aortic 
valve. In the right ventricle, the inlet valve is the tricuspid 
valve, and the outlet valve is the pulmonary (pulmonic) valve. 
Each valve consists of flaps, which function like a one-way 
swinging gate. There are a number of inherited and/or post-
natal diseases that are associated with abnormal heart valve 
development or disease. Heart valves can malfunction either 
by leaking (regurgitation), or by not opening adequately and 
partially blocking the flow of blood through the valve (ste-
nosis). Well-known diseases include aortic valve sclerosis 
(calcification) and aortic regurgitation. 
Every heartbeat has two distinct components: diastole 
and systole. During diastole, the heart relaxes and ventricles 
fill with blood; then the atria contract and force more blood 
into the ventricles. During systole, the ventricles contract and 
pump blood to the arteries; then the atria relax and begin filling 
blood again. As the valve opens and closes 70 times per minute 
on average, heart valves undergo stress fluctuations repeat-
edly due to the blood flow. In addition to gross fluctuations 
in valve movement, it is likely that there are local differences 
in tissue biomechanics throughout the valve structure.  For 
example, folding corrugations form on the aortic surface of 
the valve, and at the base of the valve where it connects to the 
heart wall.  These supplemental biomechanical deformations 
are likely to impose additional forces and modes of behavior 
on the underlying cells.
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abstract
Tenascin-C (TN-C) interacts with extracellular molecules and plays a role in cell adhesion, signaling, and 
differentiation. There is evidence that TN-C is regulated by mechanical forces and since the heart valve 
is a highly dynamic structure, it is possible that TN-C is expressed within specific sites within the aortic 
valve, as these sites are subject to unique mechanical forces. It is also reasonable to expect differences 
in TN-C expression between the pulmonary and the aortic valve because these two locations experience 
different levels of mechanical force. Here we compare TN-C expression levels in adult pulmonary versus 
aortic valves and determine if different cell types within aortic valves express different amounts of TN-
C. Our results indicate that TN-C is expressed in normal post-natal heart valves and expression is higher 
on the aortic versus ventricular side of the aortic valve. TN-C expression may be higher in aortic versus 
pulmonary valve. SMC, fibroblasts or myofibroblasts may produce TN-C, but endothelial cells appear not 
to produce TN-C. These studies will help us in determining the role TN-C plays in normal heart valve tissue 
homeostasis and how different cell types react to different mechanical forces.  
Tenascin-C (TN-C) is a large, secreted glycoprotein that 
functions outside the cell within the extracellular matrix. The 
domain structure of TN-C allows for interaction with multiple 
extracellular molecules and for multiple roles in cell adhesion, 
signaling and differentiation.  TN-C interacts with the cell sur-
face through numerous receptors, including integrins, which 
are used to send signals to the cell interior. These signals can 
instruct the cell to grow, migrate, survive, die, or differentiate, 
depending upon the cellular and extracellular context (1, 2). 
TN-C is synthesized in an ordered fashion at particular sites 
during development: It is made in large amounts by certain 
tumors (at pathological sites), and is found in restricted tissue 
locations in the adult. TN-C is also expressed in normal pro-
cesses, such as wound healing and nerve regeneration (1, 2). 
Usually, however, TN-C is suppressed in normal adult tissues. 
For example, TN-C is also expressed within the developing 
heart valve (3), and it is highly expressed in diseased valves 
where it is believed to promote sclerosis (hardening of the 
valve) (4). However, it is not known whether TN-C also plays 
a role in normal valve tissue homeostasis. 
There is significant evidence that TN-C is regulated by me-
chanical forces (5). Studies show that hemodynamic stress of 
increased pulmonary arterial flow induces TN-C (6). In keep-
ing with this, removal of mechanical stress suppresses TN-C 
expression (7). Collectively, these and other studies indicate 
that TN-C expression is regulated by tissue biomechanics, and 
that this may account for its appearance in settings where it 
plays a regenerative role, such as healing wounds.  Since the 
heart valve is a highly dynamic structure, it is possible that 
TN-C is expressed within specific sites within the aortic valve, 
because these sites are subject to unique and local mechanical 
forces.  As well, since the adult pulmonary valve, located in a 
low pressure vascular bed, experiences a different level of me-
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chanical force when compared to the adult aortic valve, which 
is subject to higher pressures, it is also reasonable to expect 
differences in TN-C expression at these two different loca-
tions. Thus, a primary goal of this project was to compare TN-
C expression levels in adult pulmonary versus aortic valves. 
 Another aim of this research project was to determine whether 
different cell types within aortic valves express different 
amounts of TN-C. There are believed to be at least 3 differ-
ent cell types in the aortic valve: The surface of the leaflet 
is covered with a layer of endothelial cells (ECs), while 
within the valve there are fibroblasts and smooth muscle cells 
(SMCs). Importantly, each of these distinct cell types can be 
identified using specific markers: ECs (von Williebrand fac-
tor), fibroblasts (fibroblast specific protein), and for SMCs 
(smooth muscle alpha–actin). By determining which cells 
express TN-C in normal heart valves, we may be able to find 
out more about the role TN-C plays in normal heart valve 
tissue homeostasis and how different cell types react to dif-
ferent mechanical forces.  
Since heart valves are highly dynamic structures subjected 
to different levels of mechanical force, we hypothesized that 
(1) TN-C would be expressed in the post-natal heart valve; 
(2) TN-C would be preferentially expressed in aortic versus 
pulmonary valve; and (3) TN-C expression would be higher 
on the aortic versus ventricular side within the same valve. To 
address these hypotheses, we used an immunohistochemical 
approach using porcine heart valves and antibodies raised 
against TN-C, and cell type specific markers.  
MaterIals	and	Methods
As mentioned above, the primary experimental approach 
used throughout the semester was immunohistochemistry us-
ing a peroxidase-based approach. Immunohistochemistry is a 
method of detecting the presence of specific proteins in cells 
or tissues. By conducting immunostaining for TN-C and for 
markers that are specific for the 3 different cell types in the 
aortic valve (i.e. vWf, fibroblast specific protein, and smooth 
muscle alpha-actin), we were able to identify if the different 
cells in the valve are surrounded by TN-C. Upon retrieving 
normal adult porcine heart valves (Landrace X Yorkshire, ~ 
250 lbs., castrated), longitudinal and transversal tissue sections 
were taken. Longitudinal sections are cut along the Arantii 
nodule, while transversal sections are along the closure line 
of the valve. To prepare for immunohistochemical analysis, 
each sample was then embedded in paraffin, and these were 
then sectioned to a thickness of approximately 7 µm. Swine 
are particularly convenient to use for research due to their 
similarities in body size and with the biology of the human, 
in particular with the heart and blood vessels.
The polyclonal primary antibodies used were anti-chicken 
TN-C antibody, anti-human von Williebrand factor (vWf) for 
ECs, and anti-human S100A4 for fibroblasts. Primary antibod-
ies were applied in dilutions of 1:500 for TN-C, and 1:2000 
for vWf. S100A4 was applied in dilutions of 1:100 and 1:200. 
Monoclonal mouse anti-smooth muscle actin antibody was 
used for immunostaining for smooth muscles cells. This was 
applied in 1:500 dilution.  Biotin was then added to bind to 
the antibody-antigen complex using biotinylated secondary 
antibodies. The secondary antibodies (all from Vectastain) 
used were biotinylated anti-rabbit IgG (for TN-C, VWf, and 
fibroblasts), and biotinylated anti-mouse IgG (SMA). For 
negative controls, normal rabbit IgG or normal mouse IgG 
was used in place of the primary test antibodies.
Samples were prepared for the immunohistochemistry 
by first removing the paraffin from the sections and this was 
followed by rehydration of tissue samples. Sections were then 
subject to antigen retrieval, which is a method to enhance 
exposure of the protein of interest to the applied antibody that 
may have been masked by fixation. A pronase digestion solu-
tion was used for TN-C and S100A4 immunostaining, while 
proteinase-K digestion was used for the vWf immunostain-
ing. For the SMA immunostaining, samples were subjected 
to antigen retrieval by placing them in citrate buffer, and then 
heating them on a hotplate after which they were allowed to 
stand at RT for 30 min. Endogenous peroxidase activity was 
blocked with methanol containing 0.3% hydrogen peroxide for 
30 min at RT, followed by washing with phosphate-buffered 
saline solution (PBS).  Nonspecific binding was inhibited with 
a solution of 1% BSA in PBS, 0.1% Tw20, and 5% normal 
goat serum for 30 min at RT.  This is necessary to eliminate 
any non-specific adsorption of the primary antibody to tissue 
elements. Immunostaining was then carried out by applying 
the appropriate concentration of primary antibody to each 
sample and incubating overnight at 4°C. For negative controls, 
normal rabbit IgG or normal mouse IgG was used in place of 
the primary test antibodies. Following incubation, the samples 
were washed repeatedly in 1% BSA and .1 % BSA and then 
were incubated with their respective biotinylated secondary 
antibody for one hour at RT. The antibody-antigen complex is 
now bound by a secondary, enzyme-conjugated, antibody. The 
avidin-biotin-peroxidase complex (ABC) was then performed 
for 30 min at RT. This allows for a complex to form between 
the avidin and biotinylated enzymes, enhancing the signal as 
the avidin has four binding sites for biotin.  The color reac-
tion was developed with the use of diaminobenzidine (DAB), 
which is a peroxidase procedure for localizing markers. The 
DAB reaction is performed to deposit a brown substrate 
where there are peroxidase enzymes present. This reaction 
was done for the same amount of time on each sample so that 
the level of TN-C expression could be compared between 
them. Thus, an assessment of relative TN-C expression can 
be completed in qualitative terms according to the resulting 
staining intensity from the DAB reaction.  Counter-staining 
was performed using hematoxylin to visualize and orient 
nuclei. Following washing and dehydration, a coverslip was 
applied to the section.
results	and	dIscussIon
To begin to determine whether TN-C is expressed in the 
biomechanically active environment of normal adult heart 
valves, and whether valves in different vascular beds express 
more or less TN-C than one another, we first compared TN-C 
expression in post-natal porcine aortic and pulmonary heart 
valves (Figure 1).  Although TN-C expression (in brown) is 
usually suppressed in normal cells, our study showed that TN-
C is expressed in the normal post-natal adult aortic porcine 
valve and it is expressed predominantly on the aortic side. This 
is interesting for several reasons: First, most cells are constant-
ly exposed to mechanical forces, but not all of them express 
TN-C. The heart is a very dynamic structure, and cells in the 
heart experience a significant amount of mechanical stress, and 
so this may be part of the reason that TN-C expression does 
not turn off in normal cells. In addition, cells on one surface 
of the valve leaflet experience a very different hemodynamic 
environment than those on the opposite surface. The aortic 
side may experience more disruptions than the ventricular 
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side due to turbulent blood flow. In fact, this may account for 
the fact that calcification and sclerosis occur predominantly 
on the aortic side of the valve leaflet, especially since TN-C 
has been shown to participate in this process (Refs).  It is also 
worthy to note that TN-C is not located on the very edge of 
the valve but, instead, there is a gap where TN-C is absent 
right along the surface of the valve. This indicates that there 
are site-specific differences and TN-C seems to be in discrete 
sections within the valve. There is also considerable variation 
of TN-C within the same valve of the same individual. This 
can be due to varied mechanics or to different cell types that 
are in these positions.  
It is useful to compare TN-C expression in aortic valve 
with the pulmonary valve for several reasons. Structurally, 
Figure 2: Site-specific differences in SM α-actin in the aortic 
valve.
TN-C is expressed at the border of the SM α-actin positive layer.  
There appears to be a sub-set of SMCs that make TN-C.  Are these really 
SMCs or are they myofibroblasts?
side. It is important to note that SMA α-actin is a marker for 
smooth muscle cells, as well as myofibroblasts. Thus, it would 
be useful to find out if these cells that seem to be producing 
TN-C are SMCs or myofibroblasts. To distinguish between 
the two types of cells, future immunostaining studies will be 
performed using myosin heavy chain (MHC) that is frequently 
used as an additional marker for smooth muscle.
We also wished to determine whether endothelial cells 
(ECs) are in contact with TN-C.  To achieve this vWF was 
  Figure 3: Site-specific differences in vWF in the aortic valve.
Figure 1: TN-C in Ao vs Pulmonary.  
Ao Valve: TN-C is strongly expressed towards the Ao side, 
and more diffusely within the valve.  
Pu. valve: TN-C is moderately expressed towards the outflow 
side & less is  evident in the interior.
the aorta is thicker than the pulmonary artery. The pulmonary 
valve experiences different types of mechanical force than 
the aortic valve. Since TN-C has been shown to be controlled 
by biomechanical forces, it would reasonable to see differ-
ences in TN-C expression because the pulmonary valve is in 
a lower pressure vascular bed. Thus, the aortic valve should 
express more TN-C if this gene is mechanosensitive. From 
examining TN-C expression in pulmonary valves, however, 
the results are not conclusive. TN-C levels may be less in 
the pulmonary valve than in aortic valves (Figure 1).  In the 
aortic valve, TN-C is strongly expressed toward the aortic 
side, as well as more diffusely within the valve. On the other 
hand, in the pulmonary valve TN-C is moderately expressed 
toward the outflow side, and is less evident in the interior of 
the valve. This suggests that the different types of pressures 
and hemodynamic forces that aortic and pulmonary valves 
experience may account for differences in TN-C expression. 
Regardless of the mechanism, it is clear that in both valves, 
more TN-C is expressed on the aortic versus ventricular side. 
These results indicate that there are site-specific differences 
in TN-C expression, and this could mean either that different 
cells are making TN-C at different sites, and/or that external 
mechanical influences on the valve differentially regulate 
TN-C within the same cell type.
To determine which cell types express TN-C, or are in 
contact with TN-C, we performed additional immunohisto-
chemical studies.  Initially we stained for smooth muscle cells 
(SMCs) using α-actin as a marker.  Figure 2 shows that SMCs 
are more heavily concentrated on the aortic side (AS) as op-
posed to the ventricular side (VS). Examining this against the 
TN-C immunostaining, TN-C is expressed at the border of 
the SM alpha-actin positive layer. However, both the TN-C 
and the SM α-actin layer do not match perfectly. Instead, there 
seems to be a sub-set of SMCs that make TN-C.  In addition, 
unlike TN-C expression, SMCs are present on the ventricular 
used as a marker of ECs.  As expected, ECs are located on 
both surfaces of the valve (Figure 3).  Although ECs are 
expressed on both sides, it was also clear that vWF staining 
was more prominent on the aortic side. This may indicate that 
the ECs on each side of the valve are behaving differently 
due to differences in tissue biomechanics.  Regardless of this 
issue, our data show that TN-C is not expressed within the 
endothelial layer.
Finally, to determine whether fibroblasts express TN-C, 
we examined expression of S100A4.  Of note, these experi-
ments showed that the aortic side contains more fibroblasts 
(Figure 4). Although it resembles and overlaps with both TN-C 
and SMCs, the band of fibroblasts does not extend as far into 
the valve and is thinner. The fibroblast cells do not match up 
precisely with TN-C either. In some cases, fibroblasts are ex-
pressed right against the edge of the endothelial layer and this 
is where TN-C is absent. Fibroblasts may also be expressed on 
the endothelial layer on the surface of the valve. Alternatively, 
it is possible that S100A4 also marks ECs. 
In summary, TN-C is expressed in normal post-natal heart 
valves and expression is higher on the aortic versus ventricular 
side of the aortic valve. In addition, TN-C expression may be 
higher in aortic versus pulmonary valve. SMC, fibroblasts, 
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of interest, because vWf expression was found to be greater 
on the aortic side. 
Future	dIrectIons
To continue this project, it would be interesting to map 
biomechanical forces throughout the valve and determine 
how this relates to TN-C expression. By measuring forces 
throughout the valve, a comparison could be made between 
TN-C expression and different mechanical forces.
Additionally, immunostaining of TN-C in the aortic versus 
the pulmonary position will be conducted to begin to deter-
mine whether hemodynamic factors differentially regulate 
TN-C. Accordingly, expression patterns of TN-C will then be 
compared in the aortic and pulmonary position in the heart 
valve to see if TN-C is expressed within specific sites.
Finally, it would be interesting to find out what exactly 
controls TN-C expression in the valve. Bone morphogenetic 
protein-4 (BMP-4) is a growth factor that is expressed on the 
aortic side endothelium, and it has been proven that BMP-4 
suppresses TN-C expression (Ihida-Stansbury and Jones, un-
published). Given that TN-C is expressed on aortic side but it 
stops short of the endothelium layer, BMP-4 may negatively 
regulate TN-C within the interior of the valve. There may be a 
gradient of BMP-4 that decreases from the endothelium layer 
toward the interior of the valve. As BMP-4 levels decrease, 
this may correlate with an increasing gradient of TN-C. 
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